PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Alan Daugherty Selected Research

Atherosclerosis (Atheroma)

06/2008	Atherosclerosis: cell biology and lipoproteins.
03/2008	Renin inhibition reduces hypercholesterolemia-induced atherosclerosis in mice.
02/2007	Bone marrow transplantation reveals that recipient AT1a receptors are required to initiate angiotensin II-induced atherosclerosis and aneurysms.
12/2006	Atherosclerosis: cell biology and lipoproteins.
02/2006	Atherosclerosis: cell biology and lipoproteins.
04/2005	Atherosclerosis: cell biology and lipoproteins.
02/2005	Aldosterone does not mediate angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
12/2004	Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor.
10/2004	Alpha(1,3)fucosyltransferases FucT-IV and FucT-VII control susceptibility to atherosclerosis in apolipoprotein E-/- mice.
06/2004	Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice.
02/2004	Atherosclerosis: cell biology and lipoproteins.
09/2003	Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.
03/2003	Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.
01/2003	Thalidomide inhibits early atherogenesis in apoE-deficient mice.
08/2002	Atherosclerosis: cell biology and lipoproteins.
08/2002	Macrophage-specific expression of class A scavenger receptors in LDL receptor(-/-) mice decreases atherosclerosis and changes spleen morphology.
06/2002	IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice.
02/2002	Interleukin-18 enhances atherosclerosis in apolipoprotein E(-/-) mice through release of interferon-gamma.

Articles by Research Topic

Disease

18	Atherosclerosis (Atheroma) 06/2008 - 02/2002
6	Abdominal Aortic Aneurysm 08/2006 - 03/2003
3	Hypercholesterolemia 03/2008 - 12/2004
2	Aneurysm (Aneurysms) 02/2007 - 09/2003
2	Vascular Diseases (Vascular Disease) 08/2004 - 04/2004
1	Aortic Rupture 09/2007
1	Hemorrhage 06/2006
1	Tissue Adhesions 09/2003
1	Gallstones (Gallstone) 05/2002

Drug/Important Bio-Agent (IBA)

11	Angiotensin IIIBA 12/2007 - 03/2003
7	ApolipoproteinsIBA 08/2006 - 02/2002
6	Lipoproteins (Lipoprotein)IBA 06/2008 - 08/2002
2	Interleukin-4 (Interleukin 4)IBA 12/2007 - 05/2002
2	LDL Receptors (LDL Receptor)IBA 06/2004 - 08/2002
2	Apolipoproteins E (ApoE)IBA 07/2003 - 01/2003
1	ReninIBA 03/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2007
1	Macrophage Colony-Stimulating FactorIBA 06/2006
1	Vitamin E FDA Link 08/2005
1	AldosteroneIBA 02/2005
1	AngiotensinsIBA 12/2004
1	FucosyltransferasesIBA 10/2004
1	Scavenger Receptors (Scavenger Receptor)IBA 09/2003
1	Doxycycline (Vibramycin)FDA LinkGeneric 03/2003
1	Thalidomide (Thalomid)FDA Link 01/2003
1	Class A Scavenger ReceptorsIBA 08/2002
1	Interferon-gamma (Interferon, gamma)IBA 02/2002
1	Interleukin-18 (Interleukin 18)IBA 02/2002

Therapy/Procedure

1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2007
1	Orchiectomy (Orchidectomy) 08/2004
1	Ovariectomy (Oophorectomy) 08/2004